Go Pro
→ Buy this stock today (From Chaikin Analytics) (Ad)tc pixel Free XTLB Stock Alerts

XTL Biopharmaceuticals (XTLB) Stock Chart & Stock Price History

XTL Biopharmaceuticals logo
$2.52 -0.06 (-2.13%)
As of 10:10 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

XTL Biopharmaceuticals Stock Price Performance

The XTL Biopharmaceuticals (XTLB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 86.57%, with a year-to-date return of 9.59%. In the past month, the stock has decreased 10.30%, reflecting recent market activity.

As of the latest close, XTL Biopharmaceuticals traded at $2.58 with a market cap of $5.68 million and volume of 2,597 shares. Five years ago, the stock traded at a split-adjusted price of $74.08, representing a 96.59% decrease over that period. At the time, it had a market cap of $23.81 million and a volume of 5,425 shares.

Receive XTLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for XTL Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-9.17%
1 Month
Performance
-10.30%
3 Month
Performance
+3.95%
Year-To-Date
Performance
N/A
1 Year
Performance
N/A
5 Year
Performance
-96.59%

XTLB Stock Chart for Thursday, August, 27, 2026

XTLB Chart by TradingView

XTL Biopharmaceuticals Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
08/26/2026$2.60$2.58
-0.77%		$2.63$2.352,597 shs$5.68 million
08/25/2026$2.65$2.60
-1.70%		$2.64$2.584,077 shs$5.72 million
08/24/2026$2.78$2.65
-4.86%		$2.66$2.631,158 shs$6.13 million
08/21/2026$2.76$2.78
+0.72%		$2.78$2.78516 shs$6.13 million
08/20/2026$2.98$2.76
-7.38%		$3.05$2.764,420 shs$6.07 million
08/19/2026$3.23$2.98
-7.74%		$3.01$2.7040,707 shs$6.56 million
08/18/2026$2.60$3.23
+24.23%		$3.52$2.5586,157 shs$7.12 million
08/17/2026$2.75$2.60
-5.45%		$2.74$2.565,129 shs$5.72 million
08/14/2026$2.80$2.75
-1.79%		$2.96$2.553,856 shs$6.05 million
08/13/2026$2.69$2.80
+4.09%		$2.80$2.723,937 shs$6.16 million
08/12/2026$2.71$2.69
-0.81%		$2.84$2.6821,808 shs$5.93 million
08/11/2026$2.87$2.71
-5.47%		$2.87$2.652,450 shs$5.97 million
08/10/2026$2.94$2.87
-2.41%		$2.89$2.691,650 shs$6.31 million
08/07/2026$2.78$2.94
+5.95%		$2.94$2.771,803 shs$6.47 million
08/06/2026$2.85$2.78
-2.63%		$2.87$2.682,467 shs$6.12 million
08/05/2026$2.78$2.85
+2.48%		$2.87$2.733,389 shs$6.27 million
08/04/2026$2.86$2.78
-2.76%		$2.96$2.6014,233 shs$6.12 million
08/03/2026$2.68$2.86
+6.56%		$2.88$2.764,334 shs$6.30 million
07/31/2026$2.85$2.68
-5.82%		$2.82$2.501,735 shs$5.92 million
07/30/2026$2.85$2.85
-0.14%		$2.93$2.793,784 shs$6.27 million
07/29/2026$2.96$2.85
-3.58%		$2.96$2.701,918 shs$6.28 million
07/28/2026$2.82$2.96
+5.15%		$2.98$2.686,196 shs$6.52 million
07/27/2026$2.94$2.82
-4.25%		$2.88$2.791,287 shs$6.19 million
Related Companies

This page (NASDAQ:XTLB) was last updated on 8/27/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel